hVIVO (HVO) Competitors GBX 16.90 -0.30 (-1.74%) As of 12:33 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesBuy This Stock HVO vs. SLN, PRTC, OXB, FARN, HZD, VRP, ARIX, BVXP, 4BB, and CIRShould you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include Silence Therapeutics (SLN), PureTech Health (PRTC), Oxford Biomedica (OXB), Faron Pharmaceuticals Oy (FARN), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Bioventix (BVXP), 4basebio (4BB), and Circassia Group (CIR). These companies are all part of the "biotechnology" industry. hVIVO vs. Silence Therapeutics PureTech Health Oxford Biomedica Faron Pharmaceuticals Oy Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Arix Bioscience Bioventix 4basebio Circassia Group hVIVO (LON:HVO) and Silence Therapeutics (LON:SLN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk. Do analysts rate HVO or SLN? Given Silence Therapeutics' higher possible upside, analysts clearly believe Silence Therapeutics is more favorable than hVIVO.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score hVIVO 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Silence Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor HVO or SLN? Silence Therapeutics received 79 more outperform votes than hVIVO when rated by MarketBeat users. However, 70.06% of users gave hVIVO an outperform vote while only 68.81% of users gave Silence Therapeutics an outperform vote. CompanyUnderperformOutperformhVIVOOutperform Votes12470.06% Underperform Votes5329.94% Silence TherapeuticsOutperform Votes20368.81% Underperform Votes9231.19% Is HVO or SLN more profitable? hVIVO has a net margin of 25.96% compared to Silence Therapeutics' net margin of 0.00%. hVIVO's return on equity of 47.93% beat Silence Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets hVIVO25.96% 47.93% 11.97% Silence Therapeutics N/A N/A N/A Do insiders and institutionals have more ownership in HVO or SLN? 34.9% of hVIVO shares are held by institutional investors. 14.0% of hVIVO shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to HVO or SLN? In the previous week, hVIVO's average media sentiment score of 0.00 equaled Silence Therapeutics'average media sentiment score. Company Overall Sentiment hVIVO Neutral Silence Therapeutics Neutral Which has stronger valuation & earnings, HVO or SLN? hVIVO has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiohVIVO£68.74M1.73£17.84M£2.426.95Silence Therapeutics£11.35M0.00N/A-£48.60N/A SummaryhVIVO beats Silence Therapeutics on 11 of the 13 factors compared between the two stocks. Get hVIVO News Delivered to You Automatically Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HVO vs. The Competition Export to ExcelMetrichVIVOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£119.16M£128.75M£5.38B£2.66BDividend Yield1.10%3.74%5.21%5.05%P/E Ratio6.953.4226.76134.07Price / Sales1.734,156.78389.94213,407.41Price / Cash4.9413.1938.2528.02Price / Book3.0333.146.803.79Net Income£17.84M-£91.56M£3.23B£5.88B7 Day Performance-7.22%3.29%1.52%0.38%1 Month Performance3.00%8.06%10.04%21.83%1 Year Performance-35.48%101.97%16.73%120.81% hVIVO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HVOhVIVON/AGBX 16.90-1.7%N/A-35.3%£119.58M£68.74M6.97N/ASLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech Health1.3487 of 5 starsGBX 130+6.9%GBX 455+250.0%-40.3%£390.50M£521,320.79-5.33300OXBOxford Biomedica2.1962 of 5 starsGBX 293.36+0.5%GBX 560+90.9%-8.1%£311.84M£98.31M-2.18891FARNFaron Pharmaceuticals OyN/AGBX 228+3.6%N/A-6.3%£306.09MN/A-6.1034HZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919BVXPBioventixN/AGBX 2,859-0.6%N/A-33.9%£149.71M£13.65M18.4912News Coverage4BB4basebioN/AGBX 1,150+2.2%GBX 1,600+39.1%-18.5%£147.32M£311,000.00-1,474.36101News CoverageGap DownCIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down Related Companies and Tools Related Companies SLN Competitors PRTC Competitors OXB Competitors FARN Competitors HZD Competitors VRP Competitors ARIX Competitors BVXP Competitors 4BB Competitors CIR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HVO) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding hVIVO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share hVIVO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HVO Stock Free HVO Stock Alerts